Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Prove the Effectiveness of PENS Therapy With Peripheral Neuropathy

NCT03540446 is registered in ClinicalTrials.gov with DyAnsys, Inc. as lead sponsor.

NCT NCT03540446
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03540446 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Prove the Effectiveness of PENS Therapy With Peripheral Neuropathy
Lead sponsor
DyAnsys, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
April 4, 2018
Completion date
October 31, 2018
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral neuropathy